Effect of Granulocyte Colony-Stimulating Factor Combination Therapy on Efficacy of Posaconazole (SCH56592) in an Inhalation Model of Murine Pulmonary Aspergillosis

Using an inhalation model of pulmonary aspergillosis, we observed modest differences in the survival rates of mice treated with granulocyte colony-stimulating factor (G-CSF) and posaconazole (POS) and those treated with POS alone. This finding is in contrast to a previous report that suggested that...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Patera, Andriani C., Menzel, Frederick, Jackson, Craig, Brieland, Joan K., Halpern, Judy, Hare, Roberta, Cacciapuoti, Anthony, Loebenberg, David
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2004
Materias:
Experimental Therapeutics
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC478512/
https://ncbi.nlm.nih.gov/pubmed/15273138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.8.3154-3158.2004
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares